This shows you the differences between two versions of the page.
Both sides previous revision Previous revision | |||
projects:workgroups:transfusion [2019/12/13 02:45] cgreich |
projects:workgroups:transfusion [2019/12/13 04:05] (current) cgreich |
||
---|---|---|---|
Line 1: | Line 1: | ||
==== OHDSI Transfusion Working Group ==== | ==== OHDSI Transfusion Working Group ==== | ||
+ | |||
+ | <WRAP box justify round> | ||
=== MISSION === | === MISSION === | ||
Line 6: | Line 8: | ||
Transfusions are special treatments which are currently in active research by the FDA BEST and the [[https://www.nhlbi.nih.gov/science/recipient-epidemiology-and-donor-evaluation-study-reds-program|REDS-IV]] program. The current OMOP CDM allows only partial capture of relevant transfusion information to support the various research use cases (see below). This Working Group intends to close that gap. | Transfusions are special treatments which are currently in active research by the FDA BEST and the [[https://www.nhlbi.nih.gov/science/recipient-epidemiology-and-donor-evaluation-study-reds-program|REDS-IV]] program. The current OMOP CDM allows only partial capture of relevant transfusion information to support the various research use cases (see below). This Working Group intends to close that gap. | ||
+ | |||
+ | </WRAP> | ||
== Use Cases == | == Use Cases == |